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Abstract: The mechanism of unidirectional transport of
sodium from blood to brain in pentobarbital-anesthetized
rats was examined using in situ perfusion. Sodium trans-
port followed Michaelis—Menten saturation kinetics with
a V~,,of 50.1 nmol/g/min and a ~ of 17.7 mM in the
left frontal cortex. The kinetic analysis indicated that, at
a physiologic sodium concentration, ~26% of sodium
transport at the blood—brain barrier (BBB) was carrier
mediated. Dimethylamiloride (25 pM), an inhibitor of
Na~/H~exchange, reduced sodium transport by 28%,
whereas phenamil (25 pM), a sodium channel inhibitor,
reduced the transfer constant for sodium by 22%. Bumet-
anide (250 pM) and hydrochlorothiazide(1.5 mM), inhibi-
tors of Na~—K~—2Cl INaCl symport, were ineffective in
reducing blood to brain sodium transport. Acetazolamide
(0.25 mM), an inhibitor of carbonic anhydrase, did not
change sodium transport at the BBB. Finally, a perfusate
pH of 7.0 or 7.8 or a perfusate Pea
2 of 86 mm Hg failed
to change sodium transport. These results indicate that
50% of transcellular transport of sodium from blood to
brain occurs through Nat/H exchange and a sodium
channel in the luminal membrane of the BBB. We propose
that the sodium transport systems at the luminal mem-
brane of the BBB, in conjunction with CVIHCO3 ex-
change, lead to net NaCI secretion and obligate water
transport into the brain. Key Words: Brain—Blood—brain
barrier—Transport—Sodium—In situ perfusion.
J. Neurochem. 66, 756—763 (1996).
The blood—brain barrier (BBB) serves not only to
restrict the movement of water-soluble solutes between
blood and brain but also to regulate the ionic composi-
tion of the interstitial fluid through transport of Na~
and K (Schielke and Betz, 1993). Previous reports
have provided evidence for both NaCI cotransport and
a nonselective sodium channel in the luminal mem-
brane of the BBB (Betz, 1983a) and for an Na~,K~-
ATPase and Na*/H+ exchange in the abluminal mem-
brane (Betz, 1983h). Vigne et al. (1989), using the
patch clamp technique, confirmed that cultured brain
endothelial cells contain a nonselective cation channel,
but they did not specify the location of the channel to
either the luminal or abluminal membrane. On the basis
of in vivo studies, Murphy and Johanson (1989) re-
ported that metabolic acidosis and arniloride but not
acetazolamide inhibit sodium transport at the BBB,
and they postulated an Nat/H exchange mechanism
in the luminal membrane. Thus, taken together, the
available data suggest the unlikely possibility that the
luminal membrane of the BBB contains three different
types of sodium transport mechanisms.
The present studies were designed to define better
the mechanisms of sodium transport at the luminal
membrane of the BBB using in situ perfusion of the
rat brain. The main advantage of in situ perfusion is
that it allows us to control precisely the concentration
of inhibitors used to study sodium transport. Finally,
because amiloride has affinity for several of the carrier-
mediated sodium transport systems and the sodium
channel, we have used the more specific amiloride ana-
logues to characterize sodium transport (Kleyman and
Cragoe, 1988).
Our basic hypothesis was that blood to brain sodium
movement is both carrier and channel mediated. The
specific questions we sought to answer were the fol-
lowing: (a) Is blood to braid sodium transport subject
to saturation kinetics? (b) Is blood to brain sodium
transport inhibited by the Na~/H~exchange inhibitor
dimethylamiloride (DMA), the sodium channel inhibi-
tor phenamil (PAM) (Kleyman and Cragoe, 1988),
the Na~ICl cotransport inhibitors bumetanide and
hydrochiorothiazide (HCTZ) (Cremaschi et al.,
1992), or inhibitors of carbonic anhydrase, such as
acetazolamide? (c) Is blood to brain sodium transport
affected by short-term (~10-min)changes in pH?
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Some of’ our results were presented in a preliminary
communication (Ennis et al., 1993).
MATERIALS AND METHODS
‘l’ransport of sodium and a-aminoisobutyric acid (AIB)
across the BBB was measured using in situ perfusion of rat
brain, as previously described (Ennis et al.. 1994). In brief,
stale, Long—Evans rats, weighing 300—450 g, were anesthe-
tied with pentoharbital (65 mg/kg). The right and left com-
ittun carotid and pterygopalatine arteries were isolated, and
tl~~terygopalatinc arteries were ligated. Catheters of PE—
5)) tubing, filled with heparinized saline, were placed in the
lell fumoral artery and in the left external carotid artery. Rats
were hepariniied (1.2 untts/g of body weight), and samples
br blood gases obtained from the left b’emoral artet’y. The
belt external carotid artery cannula was used for retrograde
p~rbusionof sheep red blood cells (RBCs) in saline at a
telilperatLtre of 37°C.The perfusate was infused at a rate of
4 uI/mm. We have previously shown that this perfusion rate
is adequate for maintenance of the EEG (Ennis et al., 1994).
A hematocrit of 0.3—0.35 was used for these studies. A
uutixtut-e of 30% oxygen and 70% air was delivered by face
iui:tsk to improve oxygenation of animals during the preper-
Itusion period. Femoral and carotid blood pressures were
c alit i nuously u’ecorded through transducers connected to the
:tu-terial catheters. Blood pressure and EEG were recorded
using a Biopac MPIOO data acquisition system. The body
teuuperatLtre was maintatned between 37.5 and 38.5°Cusing
a rectal Thermistor connected to a temperature monitor/con—
I al leu’.
Measurement of blood to brain transport during
in situ perfusion
Blood to brain permeability—surface area products (PS
prodLicts) for I 5H IAIB (0.5 pCi/mI), a marker for passive)eu’tneahulity, and ::Na~(0.5 pCi/mI)were determined using
I 0-mm perfusion. We have provided evidence that in the
pi-esence of 2 mM phenylalanine the transport of AIB from
blood to brain occurs only by passive transport drtring the
It) ruin used for current in situ perfusion experiments (Ennis
et al., 1994). The PS product for [1H]AIB was measured
for all animals in this study. Supplemental pentobarhital (22
tug/kg) was given Just before perfusion to prevent the ani-
itials awakening during the perfusion. Following the perfu-
sion, the brain was removed, and the hemispheres were bi-
sected and dissected into frontal, parietal, and occipital corti-
ecs and diencephalon. Brain and perfusion fluid samples
were dissolved in rnethylbenzthonium hydroxide and pre-
pared for liquid scintillation counting.
(‘omposition of perfusion fluids
Blood was stored at 4°Cuntil the day of use. Whole blood
was centrifuged at 1,660 g for 10 mm at 8°C.and the plasma
itid white blood cells were discarded. The lightly packed
R RCs were washed twice by centrifugation in 1,5 volumes
of 0.9% NaCI and twice by centrifugation in 1.5 volumes of
perfusate saline. After the final spin, the RBCs were filtered
thi’ough nylon mesh (pot-c size, ISO pm) and resuspended
at a hematocrit of 0.3 in the perfusate. The composition of
the control saline used to make the RBC-containing perfusate
was 118 mM NaCI, 3 mM KCI, 1.2 mM MgSO
4, 1.2 mM
KH:P04. 24 mMNaHCO5, 2.5 mM CaC12, 10 mM glucose,
and 2 mM phenylalanine. The perfusate containing radioac-
tive isotopes was gently bubbled with a mixture of oxygen
and carbon dioxide to maintain the pH in the range 7.35—
7.45. Inhibitors of ion transport were dissolved in saline and
included in the final perfusate at the concentrations given in
the text.
The perfusates with a reduced sodium concentration were
mixtures ot’ Tris-HCI, Tris-base, and 24 mM Tris-carhonate
as substitutes for NaCI and NaHCO3. Sodium and potassium
concentrations were confirmed using a flame photometer (IL
943), and chloride levels were measured using a chlorido-
meter (Haake-Buchler Instruments).
Normocapnic perfusates with either a low or high pH were
ci’eated by changing the amount of NaHCO~,along with
appropriate changes in the amount of NaCI included in the
perfusate, to maintain a constant osmolality. The low pH
perfusate contained 130 mM NaCI, 3 mM KCI, 1.2 niM
MgSO., 1.2 mM KH2PO4, 9.98 mM NaHCO5, 2.5 mM
CaCL, 10 mM glucose. and 2 mM phenylalanine with a pH
of 7.01 ±0.01. The high pH perfusate contained 77 mM
NaCI, 3 mM KCI, 1.2 mM MgSO4, 1.2 mM KH2PO4, 62.9
mM NaHCO1, 2.5 mM CaCI2. 10 mM glucose, and 2 mM
phenylalanine with a pH of 7.76 ±0.01. The hypercapnic
perfusate. with a normal pH, contained 91.9 mM NaCI. 3
mM KCI. 1.2 mM MgSO4, 1.2 mM KH2PO4, 50.1 mM
NaHCO~,2.5 mM CaCl2, 10 mM glucose, and 2 mM phe-
nylalanine with apH of 7.35 ±0.01 and Pco2 of 85.6 ± 1.61
mm Hg.
Calculation of rate constants for BBB
permeability to AIB and Na~
The rate constant for movement of solute across the BBB
was calculated from the following equation:
K = A5/(C1,>< T) (I)
where A1, is the amount of solute in the brain per unit mass
of tissue (dpm/g), C1, is the perfusate solute concentration
(dpm/ml), and T is time. In the present experiments C~is
constant.
The K, values measured in this study were <1% of the
rate of blood flow that we reported pi’eviously for in situ
perfusion of the rat brain (Ennis et al., 1994). Consequently,
K, closely approximates the PS product as described by Fen-
stermacher et al. (1981). The PS produt~tfor a substance at
the BBB is the product of the permeability (I’) (cnilmin)
and the surface area (S) (cm~/g).
Uptake data were corrected for the amount of tracer that
remains within the vascular space of the brain by the follow-
ing equation:
A~,= A — (pCPV>< C1,) (2)
where the pCI’V is the perfusate cerebral plasma volume.
An average pCPV in the present study was determined in
separate groups of animals, from the amount of LH]inulin
in the brain samples (assuming no tissue uptake).
The transfer constant for sodium was also determined
from a multiple time/graphical analysis. The following equa-
tion describes the relationship between the amount of tracer
in the brain (A1,) and its concentration in plasma:
Ah = K x J’Ci~dt+ V, + C5( T) (3)
where V~,is the sum of the plasma and rapidly filling spaces
(V5 = pCPV + Vr). V5 is termed the rapidly filling space
because it rapidly and reversibly exchanges with plasma
(Patlak eta!., 1983). Under initial velocity conditions, a plot
J. Neurorhrm., Vol. 66, No. 2, 1996
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of A
5/C~,(T)versus perfusion time is a straight line with the
slope = K, and the v-intercept = V1,.
The time of isotope circulation ranged between 6 and 18
mm. The transfer constant for sodium was measured in two
groups of animals: (a) animals perfused with sheep RBCs
in a saline containing a physiological sodium concentration
(n = 11) and (b) animals perfused with sheep RBCs in a
saline containing a low sodium concentration (0.2 mM) (n
= 10).
Kinetics of transport from perfusate to brain
Carrier-mediated, unidirectional influx at the BBB is com-
monly described by the Michaelis—Menten equation (Pard-
ridge, 1983). Because v = PS x C, where v is the velocity
of transport and C is concentration, then
PS = (V~5)/(K~,+ C5) + K~ (4)
where V,~,5is the maximal velocity of transport, K~,is the
affinity constant, and KD is the diffusion constant. When K,
PS. the capillary concentration does not change apprecia-
bly as a result of uptake into the brain, and C~approximates
the mean capillary concentration.
Carrier-mediated sodium uptake across the BBB was in-
vestigated in a group of 22 animals in which perfusate so-
dium concentration was varied between 0.5 and 137 mM.
The PS products for both [
3HIAIB and 22Na were measured
in these animals. The data were fitted to Eq. 4 using nonlinear
regression analysis.
Perfusate cerebral blood flow (,pCBF)
The pCBF was calculated using ‘4C-labeled iodoantipy-
rine as the blood flow indicator. The uptake of iodoantipyrine
is flow-limited at a pCBF of <1.8 ml/g/min (Sakurada et
al., 1978). Under these conditions, the pCBF was calculated
as follows:
pCBF = —3.2 ln [I — A
5/(0.8 x Ci,)]
Animals were preperfused for 10 mm with the appropriate
solution before the pCBF was determined. Radiolabeled io-
doantipyrine was perfused into the external carotid artery
for 15 s to measure pCBP.
Statistical analysis
Data for single time point PS products (Eq. 1) were ana-
lyzed using a model 1 ANOVA with either an unpaired, two
tailed t test or with a two-tailed Dunnett’s post hoc test for
multiple comparisons. The Systat statistical software was
used for these comparisons. Transfer constants using a
graphical analysis were calculated by least squares regres-
sion analysis of the data fit to Eq. 3. The results were sub-
jected to an analysis of covariance with a two-tailed t test.
The transport constants for Eq. 4 were calculated by a nonlin-
ear, least squares regression analysis, using the BMDP-3R
program. A p value of <0.05 was considered significant.
Chemicals and radiotracers
[
3HIAIB, [3H]inulin, 4C-labeled iodoantipyrine, and
Na were purchased from Du Pont-NEN (Boston, MA,
U.S.A.). DMA was purchased from Research Biochemicals
International (Natick, MA, U.S.A.). All other chemicals
were obtained from Sigma Chemical Co. (St. Louis,
MO, U.S.A.).
TABLE 1. Physiological parameters
Mean±SD n
Animal parameter
Weight (g) 368 ±47 18t)
Femoral blood pressure (mm Hg) 116 ± 14 18t)
Arterial pH 7.34 ±0.05 180
Arterial Pco
2 (mm Hg) SI ±6 180
Arterial P02 (mm Hg) 138 ±49 180
Arterial hematocrit (%) 42 ±3 180
Blood glucose (ing/dI) 118 ± 19 159
Plasma sodium (mEq/L) 144 ±5 180
Plasma potassium (mEq/L) 4.0 ±0.6 180
Plasma chloride (mEq/L) 106 ±6 165
Plasma osmolality (mOsm) 292 ± 10 180
Perfusate parameter
Perfusion pressure (mm Hg) 96 ±30 180
pH 7.38 ±0.! 152
Pco2 (mm Hg) 37 ±7 164
P02 (mm Hg) 300 ±74 177
Hematocrit (%) 32 ±3 180
Blood glucose (mg/dl) 231 ±40 155
Sodium (mEq/L) 138 ±3 152
Potassium (mEqfL) 4.2 ±0.6 180
Chloride (mEq/L) 114 ± IS 165
Osmolality (mOsm) 283 ±8 180
Perfusion pressure is the carotid pressure minus the pressure due
to the carotid cannula.
RESULTS
Table 1 presents the average values for blood gases,
physiological parameters, and plasma osmolality and
sodium, potassium, and glucose concentrations. These
data were measured just before the beginning of a
perfusion. These parameters were measured for the
(5) perfusate and are also included in Table 1. Perfusions
in which the sodium concentration was manipulated
are not included in Table I. The values for these all
parameters were significantly different (p ~ 0.001)
between plasma and perfusate. Before starting these
experiments we realized it would not be possible to
match plasma and perfusate exactly and chose to set
the values for the perfusate as presented in Table I.
The small differences between plasma and perfusate
are probably not physiologically significant.
Graphical analysis of sodium transport
Patlak et al. (1983) have shown that the use of
graphical analysis of multiple-time uptake data allows
the evaluation of the unidirectionality of transport and
the influx rate constant, without the need for a correc-
tion for the vascular space. We used this method in
our initial determination of the rate constant for Na~
influx across the BBB. Figure I presents a graphical
analysis for Na~uptake in the frontal cortex using in
situ perfusion with a perfusate containing either a nor-
mal (138 mM) or a low (0.2 mM) sodium concentra-
tion. Inspection of the regression lines for linearity for
both high and low sodium perfusates indicates that
during the 18 mm of the perfusion, sodium transport
.1. Ns.’urorhs’m., Vol. 66, No. 2, 1996
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FIG. 1. Graphical analysis of
BBB permeability to sodium
during perfusion with a perfu-
sate with either a sodium con-
centration of 138 mM (C); nor-
mal Na; n = 11) or 0.2 mM.;
low Na; n = 12). Datawere best
fit by linear regression analysis
to Eq. 3, where slope = K, and
intercept = V,. K, = 1.1 ±0.2
~il/g/min, V, = 7.7 ±2.2 pl/g, r
0.83, p -~ 0.002 for normal
sodium; K = 3.2 it 0.3 pl/g/min, V, = 5.0 ±3.3 pl/g, r = 0.95,
p -: 0.001 for bow sodium. Data are mean ±SE (bars) values.
t-eniained unidirectional. The transfer constant for Na~
during perfusion with a normal sodium concentration
was 1.1 ±0.2 pl/g/mmn with a rapidly filling space of
5.3 ±2.8 p11g. Data are mean ±SE values. The
transl’er constant during in situ perfusion with a low
odium perfusate was significantly increased (p
0.001 by !test) to 3.2 ±0.4 pllglmmn, as anticipated
‘or carrier-mediated transport at the BBB. Carrier-me-
diated transport is subject to self-inhibition, and there-
fore a low sodium concentration should result in a
significant increase in the transfer constant for sodium.
l’hese results confirm carrier-mediated transport for
sodium at the BBB. In addition, the demonstration of
unidirectional sodium transport during a 20-mm perfu-
sion validates the use of 10-mm, single time point
stitdies for the remainder of this study.
Kinetics of sodium transport in the frontal cortex
Figure 2A presents the sodium PS product as a func-
tion of the sodium concentration in the perfusate. These
data were best fit by nonlinear least squares regression
FIG. 2. Kinetic analysis of sodium transport from blood into the
frontal cortex. A: Sodium PS product as a function of sodium
concentration in the perfusate. Data were best fit by nonlinear
regression analysis to Eq. 4 in a group of 22 animals, where ~
:50.1 ±11.8 nmol/g/min,K~,= 17.7 ±4.1 mM, andKD = 0.88
0.11 pl/g/min. B: Data from A were averaged at each sodium
concentration and multiplied by the sodium concentration to give
the total flux. Also shown is the fraction of the total sodium flux
that proceeds either through carrier-mediated transport or by
diffusion. Lines for the total, nonsaturable, and carrier-mediated
flux are drawn by interpolation through the points predicted by
Eq. 5 and the kinetic constant from A. Data are mean ±SE
(bars) values.
FIG. 3. Effect of inhibitors of sodium transport on the AIB and
Na PS products or the ratio of Na/AIB. The inhibitors, either 25
pM DMA or 25 pM PAM, were included in the perfusate during
a 10-mm perfusion. Groups were compared using ANOVA with
a Dunnett’s test for multiple comparisons: *p 20 0.05, ~ 20 0.01
versus control. Data are mean ±SE (bars) values.
analysis to Eq. 4. Va,, the maximal velocity of trans-
port, was 50.1 ±11.8 nmol/g/min, whereas the affinity
constant, K,,,, was 17.7 ±4.1 mM. Also shown is the
diflusion constant for sodium at the BBB, which had
a value of 0.88 ±0.11 ~.tl/g/min. The PS product for
AIB (data not shown) did not change from control
values in perfusates with a reduced soditim concentra-
tion.
Multiplying the PS product for sodium by its con-
centration, C, in the perfusate gives the unidirectional
flux. Figure 2B shows the total sodium flux into the
brain as a function of perfusate sodium concentration.
Also presented are the curves describing the carrier-
mediated fraction and the nonsaturable portion of the
total flux that moves by diffusion, either through ion
channels or through membrane pores. At a soditim
concentration of 140 mM the carrier-mediated fraction
represents ‘~28%of the total flux.
inhibition of blood to brain sod!um transport
The advent of the new generation of more specific
amiloride analogues permits the identification of van-
otis Na transport processes (Kleyman and Cragoe,
1988). Figure 3 presents data on the effect of the ami-
bride analogues DMA and PAM on the PS products
for AIB and Na~products during a ID-mm perfusion.
DMA, an inhibitor of Na /H0 exchange, at a concen-
tration of 25 pM reduced the blood to brain sodium PS
product by 28% (p 0.01 by Dunnett’s test) without a
significant change in AIB permeability. The sodium
channel inhibitor PAM (25 pM) also reduced unidirec-
tional sodium influx by 22% (p 0.05).
In contrast to the amiloride analogues, inhibitors of
Na 1 IK~/2CL or NaCI symport were ineffective in
reducing blood to brain sodium transport. Table 2 pre-
sents data for the effect of’ these inhibitors on sodium
transport during in situ perfusion. The relatively high
concentrations of 250 pM bumetanide or 1.5 mM
HCTZ were without effect on sodium or AIB uptake.
Figure 4 presents the effect of acetazolamide (0.25
mM) included in the perfusate during a 10-mm expeni-
.1. Neuros’Iss’n,.. Vol. 66, No. 2. 1996
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Control 1.63 ±0.07 1.22 ±0.05 11
Bumetanide (250 pM) 1.51 ±0.!)) .20 ±0.08 9
HCTZ (1.5 mM) 1.69 ±0.18 1.49 ±0.21 6
Data are meats ±SE values.
ment. Acetazolamide could lead to a decrease in the
sodium PS product through an inhibition of carbonic
anhydrase present in the brain capillary endothelial
cells (Ghandour et al., 1992). Inhibition of carbonic
anhydrase could lead to an increase in the pH of the
brain capillary endothelial cell. This change in cellular
pH cotild decrease the H~gradient across the luminal
membrane of the brain capillary endothelial cell (from
cell to blood) and result in an inhibition of Na~/H~
exchange. Acetazolamide at this concentration had no
effect on either the sodium PS or AIB PS product.
Also included in the legend for Fig. 4 are the pH and
Pco2 for the control and acetazolamide-containing per-
fusates. There were no significant differences in these
parameters.
The presence of DMA-sensitive Na I IH~exchange
at the BBB led us to hypothesize that a decrease in
blood pH would decrease the sodium PS product by
decreasing the H I gradient across the luminal mem-
brane of the brain capillary endothelial cell. Using sim-
ilar reasoning we speculated that an increase in blood
pH might stimulate Na~transport by increasing the
W gradient from the capillary endothelial cell to
blood. Table 3 shows that perfusion of the brain with
normocapnic blood at a pH of 7.0 or 7.76 did not result
in a change in either the AIB or sodium PS product.
Also presented in Table 3 is an experiment in which
the pH was normal at a value of 7.4 but the PCO2 was
increased to 86 mm Hg. An increase in blood PC02
failed to increase significantly the sodium PS product.
We expected that an increase in the H + concentration
within the capillary endothelial cells due to the action
of carbonic anhydrase on the increased CO2 level
would stimulate transport through the Na~/H~ex-
changer in the luminal membrane. We speculate that
FIG. 4. Effect of acetazolamide on
the AIB and Na PS products or the
ratio of Na/AIB. Acetazolamide
(0.25 mM) was included in the per-
fusate during a 10-mm perfusion.
Groups were compared using an
unpaired ttest. Dataare mean ±SE
(bars) values.
the increase in the PCO2 of the perfusate during the 10-
mm perfusion did not lead to a significant increase in
the H + concentration of the brain endothelial cell.
There was a small, <9 mm Hg, difference in the
PCO2 of the control and low pH perfusates. This differ-
ence was not considered important because a 52 mm
Hg increase in the PCO2 did not significantly change
the sodium PS product.
Cerebral plasma volume and blood flow
The calculation of an accurate PS product requires
the determination of the plasma volume (Eq. 2). The
pCPV and the pCBF for experimental conditions and
substances that were thought to have potential for
changing pCPV and pCBF are presented in Table 4.
Only the normocapnic perfusate with a pH of 7.76
resulted in a significant change in the pCPV.
The pCBE was significantly increased by a hyper-
capnic (PC02 = 84 mm Hg) perfusate with a physio-
logical pH (7.38) by 65% (p 0.001). Current evi-
dence supports the idea that an increase in blood PCO2
results in a decrease in the pH of the extracellular fluid
of the brain, causing a vasodilatation and an increase
in the cerebral blood flow (Siesjo and Ingvar, 1983).
Similarly, a normocapnic perfusate with a pH of 7.03
also significantly increased (p ~ 0.001) the pCBF,
probably through an increase in the H~content of the
interstitial fluid of the brain. Again, there was a small
increase in the PCO2 of the low pH perfusate, which
we did not consider physiologically relevant.
The pCBF was also increased by acetazolamide (I
mM), from 1.03 ±0.04 ml/g/min for control animals
to I .34 ±0.04 ml/g/min for treated animals. Aceta-
zolamide is thought to lead to cerebral hypercapnia
and extraceblular acidosis (Bickler et al., 1988). The
effect of 25 pM DMA in the perfusate is also included
in Table 4. Because this concentration of DMA pro-
duced a 28% decrease in the sodium PS product, we
thought that the pH of the’brain capillary endothelial
might also decrease and lead to an increase in the
pCBF. DMA had no significant effect on the pCBF,
which may indicate that a larger change in pH is re-
quired to increase cerebral blood flow. These results
on pCBF indicate that the perfused rat brain is able to
respond in a physiological fashion to known stimuli
and confirm the viability of the preparation.
DISCUSSION
We have shown previously that in situ perfusion
using sheep RBCs maintains the EEG and the pCPV
and pCBF within the normal range of in vivo values,
indicating that the technique provides adequate perfu-
sion of the rat brain (Ennis et al., 1994). All of the
animals in the present study had an intact EEG during
the time course of a perfusion.
Sodium transport from blood to brain
The mechanisms of blood to brain sodium transport
are not well characterized. It has been proposed that
.1. Neuro, ‘he/n., Vol. 66, .5< 2, /996
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TABLE 3. Eftect ofpH and Pco




Low pH/normal Pco1 7.01 0.01” 41.8 ±2.1” 1.05 ±t).16 1.27 ±0.19 6
Control 7.36 ± (1.01 33.1 ± 1.1 1.23 ±0.1!) 1.42 ±0.14 12
High pH/normal Pco2 7.76 ±0.01” 36.1 ± 1.0 1.43 ±0.06 1.27 ±0.06 7
Normal p1-1/high Pco2 7.35 ±0.01 85.6 ± 1.6” 1.51) ±0.16 1.75 ±0.21 10
Data are mean ±SE values.
~ 0.001 for comparison of control versus modified condition.
blood to brain sodium movement is by diffusion
lhrough neutral pores in the paracellular pathway,
based on symmetrical diffusion potentials and the lack
of’ selectivity to Nat, K~,and C1 (Crone, 1984).
The very low permeability of sodium at the BBB was
resolved through postulating a small number of these
pores (Crone, 1984). Damage to the microvessels dur-
ing these experiments and the observation that K~ex-
Itihits a seven to 10 times higher permeability at the
I3BB than Na~were cited as evidence against the hy-
1othesis that pores provide the major route for ion
transport across the BBB (Schielke and Betz, 1993).
Using in situ perfusion we have studied sodium trans-
Port at the luminal membrane of the BBB with a tech-
nique that is not hampered by the limitations of other
methods (Takasato et al., 1984; Ennis et al., 1994).
‘ihe main advantage of in situ perfusion is the ability
to study unidirectional transport at a constant blood
low, with a perfusate of known composition. As an
example, the only previous determination of the kinet-
ics of sodium transport from blood to brain used the
intracarotid single injection technique (Betz, l983a).
‘l’he kinetics of sodium transport were determined rela-
live to those of L-glucose and showed a K~,of 2.5 mM.
This value for the K,,, is a factor of 8 less than the
17.7 mM from present study and probably reflects the
mixing of a bolus injection with blood (Pardridge,
l’)83).
It is interesting that at a sodium concentration of
140 mM, the carrier-mediated portion of sodium flux
represents 26% of the total flux, which is very similar
to the 28% inhibition that results from including 25 pM
DMA in the perfusate. The similarity between these
numbers suggests that 25 p.M DMA completely inhib-
its the luminal Na~/H~exchanger. The K,,,, deter-
mined from the kinetics of sodium transport, of 17.7
mM is within the range of values of 15—18 mM char-
acteristic of the different isoforms of Na~/H~ex-
changers (Levine et al., 1993).
Another 22% of the unidirectional sodium flux is
mediated by a PAM-sensitive transport system. A
PAM-sensitive, nonselective cation channel with a
conductance of 23 pS has been reported in cultured
brain microvascular cells (Vigne et al., 1989). A non-
selective cation channel with similar biophysical prop-
erties that is inhibited by atrial natriuretic peptide, in-
tracellular cyclic GMP, and cyclic GMP kinase has
also been reported in inner medullary collecting duct
(Light et al., 1990). The luminal membrane of brain
capillaries contains atrial natriuretic peptide receptors
(Ermisch et al., 1991) coupled to guanylate cyclase
(Steardo and Nathanson, 1987). Atrial natriuretic pep-
tide inhibits amiloride-sensitive sodium transport in
isolated brain capillaries (Ibaragi et al., 1989).
Metabolic acidosis and alkalosis and a respiratory
acidosis were all ineffective in changing the rate of
sodium transport from blood to brain during a 10-mm
exposure. In contrast, other investigators have pre-
sented evidence that a metabolic acidosis of 1 h in
duration reduced the sodium PS product by 25% (Mur-
phy and Johanson, 1989). The time of exposure to the
altered blood pH is the main difference between these
studies and probably accounts for the different results.
Recently the isoform of carbonic anhydrase desig-






Low pH/normal Pco2 7.03 ±0.0!” 45.6 ±2.4” 3.88 ±t).19 1.52 ±0.08” 5
Control 7.34 ± 0,01 36.8 ±1.2 3.64 ±0.18 1.03 it 0.06 II
High pH/normal Pco2 7.76 ±0.01” 38.1 ± 1.5 2.58 ±0.22’ 0.96 ±0.07 7
Normal pH/high Pco2 7.38 ±0.01 84.4 ±2.3” 2.67 ±0.35 1.70 ±0.06” 3
DMA (25 pM) 7.40 ±0.01 34.0 ± 1.6 3.67 ±0.46 1.08 ±0.07 5
Acetazolamide (1 mM) 7.40 ±0.03’ 34.4 ±1.2 2.92 ±0.51 .34 ±0.04’ 4
Data are mean ±SE values.
“p 20 0.001, h~ ~ 0.01, ‘p ~ 0.05 for comparison of control versus modified conditions.
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FIG. 5. Model of blood to brain sodium transport.
nated CA IV, which catalyzes the reaction of CO2 and
H2() to form H + and HCO3 -, has been identified on the
luminal membrane of the brain capillary (Ghandour et
al.. 1992). The localization of this membrane-bound
isoform of carbonic anhydrase on the luminal side of
the BBB led us to hypothesize that inhibition by acet-
azolamide would reduce sodium transport. Our data
with acetazolamide confirm the results of Murphy and
Johanson (1989) that production of W by carbonic
anhydrase is not rate limiting for the Na
0/H~ex-
change mechanism of the luminal membrane of
the BBB.
These transport systems, along with the Nat, K~-
ATPase located in the basolateral membrane of the
BBB. are thought to provide the driving force for net
sodium and water secretion (Schielke and Betz, 1993).
Figure 5 presents our current model for sodium trans-
port at the BBB. We have included a CL/HCO
3
exchanger in the luminal membrane that requires ex-
perimental verification. This transport system along
with the DMA-sensitive Na’ !H
0 exchang r would
lead to neutral NaCI transport across the BBB, as oc-
curs in epithelia (Cremaschi et al., 1992). Our reason-
ing is that simultaneous Na~/H~and CL/HCO
3 ex-
change could provide for coupling between Na~and
Cl transport as has been shown for epithelia (Crem-
aschi et al., 1992). In addition, other investigators have
shown carrier-mediated chloride transport at the BBB
that is not linked to Na~transport (Smith and Rapo-
port, 1984).
The model also includes an Na~/H
0exchanger in
the abluminal membrane. This tr nsport system was
identified from the effect of amiloride on isolated rat
brain capillaries (Betz, 1983h). The Na~/H0 ex-
changers are recognized as a gene family consisting
of at least four isoforms, designated NHE 1 —4. NHE
I is probably expressed in all mammalian cells, located
in the hasolateral membrane and functions in pH and
volume regulation. In contrast, NHE 3 is thought to
reside primarily in the apical membranes in epithelial
cells and to function in neutral NaCI transport involv-
ing a CL!HCO~ exchanger (Levine et al., 1993; Tse
et al., I 993a,h). It is an attractive hypothesis to suggest
that the brain capillary endothelium may also have
asymmetrical expression of the Na ‘/H ‘ exchange iso-
forms based on similar functional considerations.
Our data suggest that the DMA-sensitive Na /H’
exchanger and the PAM-sensitive soditim channel are
located in the luminal membrane of the BBB. The
low concentrations used, combined with the very short
exposure time of 10 mm, would most likely not allow
either DMA or PAM to penetrate into the brain extra-
cellular space to a sufficiently high concentration to
inhibit Na~transport at the abluminal membrane. Fur-
thermore, these low concentrations should not inhibit
other cellular process such as the Na K’ -ATPase or
oxidative metabolism (Frelin et al., 1988; Kleyman
and Cragoc, 1988). The observation that DMA and
PAM reduce blood to brain sodium transport suggests
that the luminal membrane may be rate limiting for
transendothelial transport of sodium. Confirmation of
our speculation on the location of these transport sys-
tems in the luminal membrane of the BBB will require
further experiments such as immunohistochemistry
with specific antibodies to identify these proteins as
has been done for CA IV (Ghandotir et al., 1992) or
the glucose transporter (Gerhart et al., 1989).
Improved knowledge of the mechanisms of ion
transport may allow the use of specific drug therapy
to reduce edema formation during the early phase of
focal cerebral ischemia (Betz et al., 1989h). The first
6 h of cerebral ischemia is characterized by a net in-
crease in content of brain cations that accounts for the
net increase in brain water (Young et al.. 1987; Betz
et al., 1989a; Menzies et al., 1993). Furthermore, the
rate of sodium transport appears to be selectively in-
creased during this period of ischemia (Ennis et al.,
1990; Schielke et al., 1991; Dickinson and Betz. 1992)
through a stimulation of Na ‘,K ‘ -ATPase (Schielke et
al., 1991). The more specific amiloride analogues may
permit targeting of these sodium transport systems to
reduce edema formation during focal cerebral isch-
emia.
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